tiprankstipranks
Rhythm Pharmaceuticals Inc (RYTM)
NASDAQ:RYTM
Holding RYTM?
Track your performance easily

Rhythm Pharmaceuticals (RYTM) Financial Statements

445 Followers

Rhythm Pharmaceuticals Financial Overview

Rhythm Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-4.338; its P/E ratio is -14.30; Rhythm Pharmaceuticals is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is $-0.75. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 33.25M$ 29.08M$ 25.97M$ 24.23M$ 22.50M
Gross Profit$ 29.42M$ 26.13M$ 23.16M$ 21.00M$ 20.09M
EBIT$ -43.88M$ -27.18M$ -136.32M-$ -43.80M
EBITDA$ -43.50M$ -26.79M$ -133.96M-$ -39.05M
Net Income Common Stockholders$ -44.97M$ -33.56M$ -141.37M$ -41.63M$ -44.16M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 298.39M$ 319.13M$ 201.20M$ 275.85M$ 299.26M
Total Assets$ 363.57M$ 381.85M$ 258.65M$ 332.75M$ 354.20M
Total Debt$ 4.03M$ 4.12M$ 1.08M$ 1.26M$ 1.44M
Net Debt$ -294.36M$ -315.01M$ -200.12M$ -274.59M$ -297.82M
Total Liabilities$ 210.88M$ 342.50M$ 197.07M$ 162.99M$ 156.72M
Stockholders Equity$ 11.21M$ 39.34M$ 61.58M$ 169.76M$ 197.47M
Cash Flow-
Free Cash Flow$ -25.71M$ -29.08M$ -80.74M-$ -29.52M
Operating Cash Flow$ -25.21M$ -29.08M$ -40.74M$ -29.38M$ -29.25M
Investing Cash Flow$ -90.82M$ -8.56M$ 30.05M$ 22.64M$ -94.96M
Financing Cash Flow$ 2.49M$ 146.18M$ 4.24M$ 2.42M$ 73.04M
Currency in USD

Rhythm Pharmaceuticals Earnings and Revenue History

Rhythm Pharmaceuticals Debt to Assets

Rhythm Pharmaceuticals Cash Flow

Rhythm Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis